DIO Corporation (KOSDAQ:039840)
South Korea · Delayed Price · Currency is KRW 10,990
-80 (-0.72%)
Sep 2, 2026, 3:30 PM KST
DIO Corporation Market Cap
DIO Corporation has a market cap or net worth of 145.82 billion as of September 1, 2026. Its market cap has decreased by -35.12% in one year.
Market Cap
145.82B
Enterprise Value
183.29B
Revenue
174.45B
Ranking
n/a
PE Ratio
7.80
Stock Price
10,990.00
ChartMarket Cap Chart
Since March 1, 2001, DIO Corporation's market cap has increased from 25.42B to 145.82B, an increase of 473.63%. That is a compound annual growth rate of 7.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 145.82B | -35.52% |
| Dec 30, 2025 | 226.14B | 1.27% |
| Dec 30, 2024 | 223.31B | -31.36% |
| Dec 28, 2023 | 325.35B | 11.83% |
| Dec 29, 2022 | 290.93B | -47.39% |
| Dec 30, 2021 | 553.05B | 17.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 68.71T |
| Celltrion | 45.77T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 9.28T |
| Ilyang Pharmaceutical Co.,Ltd | 152.36B |
| Hana Pharm | 149.29B |
| Anterogen.Co.,Ltd. | 148.59B |
| Jeil Pharmaceutical Co.,Ltd | 147.17B |